The Need

Wound infections account for millions of deaths worldwide each year and trigger tremendous healthcare costs -more than 4 billion EUR a year in USA and Europe.

Currently, wounds account for almost 4% of total health system costs, and this proportion is increasing. Thus, wounds represent a significant and growing challenge to our healthcare systems.

Antimicrobial resistance (AMR) to antibiotics increases, and other anti-infective treatments available for wounds have various negative side-effects. Therefore, new cost-efficient non-antibiotic treatments for wounds are needed.

Read more about: